M

MyOme

Clinical-grade genome sequencing for disease risk

Laboratory Director

Diagnostics & Laboratory ProfessionalsPosted on Nov 6
Full-time

About the Job

Requirements

  • MD, DO, or PhD with relevant board certification and qualifications to direct the laboratory’s high-complexity testing.
  • California license; New York license preferred.
  • At least 5 years of experience in clinical molecular diagnostics, including leadership, genomic interpretation, and reporting.
  • A track record of taking assays from development through validation into routine clinical use.
  • Deep knowledge of next-generation sequencing, human genetics, variant interpretation, and laboratory quality systems.
  • Experience with long-read sequencing, laboratory scaling, automation, and New York State submissions is preferred.

Responsibilities

  • Oversee test performance, variant interpretation, and report sign-out within the authorized scope.
  • Drive validation and clinical implementation with Research and Development and Bioinformatics, defining controls, acceptance criteria, and test limitations.
  • Hire, mentor, and develop laboratory staff with clear expectations and accountability.
  • Help implement whole genome sequencing, long-read platforms, automation, and improved laboratory information management system workflows.
  • Improve turnaround time, capacity, and cost while maintaining testing quality.

Desired Qualifications

  • New York license preferred.
  • Experience with long-read sequencing, laboratory scaling, automation, and New York State submissions.

About the Company

MyOme

Clinical-grade genome sequencing for disease risk

MyOme provides clinical-grade whole genome sequencing to assess disease risk for individuals and families. It uses comprehensive genome data combined with AI and machine learning to generate integrated disease risk scores that update over time as lifestyle changes occur, delivering actionable insights for lifelong health management. The company differentiates itself by offering a single, detailed genetic test that yields evolving, lifetime risk evaluations rather than a one-off report, targeting both common and rare diseases. Its goal is to enable earlier health interventions and better disease management through personalized, data-driven genetic information.

Company size
51-200
Company stage
Series B
Total funding
$23M
Headquarters
Palo Alto, CA
Founded
2017

Recently Posted Jobs

Explore more opportunities at MyOme

See more jobs